Health-related quality of life and utility in patients with age-related macular degeneration

Archives of Ophthalmology

Volumn 125, Issue 7, 2007, Pages 945-951

  Sahel, José Alain ^a   Bandello, Francesco ^c   Augustin, Albert ^d   Maurel, Frédérique ^e   Negrini, Cristina ^f   Berdeaux, Gilles H ^b,g  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

^c UNIVERSITY OF UDINE   (Italy)

^d Augenklinik   (Germany)

^e Aremis Consultants   (France)

^f Pbe Consulting   (Italy)

^g Alcon France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CROSS-SECTIONAL STUDY; DRIVING ABILITY; FEMALE; FRANCE; GERMANY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RETINA MACULA AGE RELATED DEGENERATION; SEX; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISUAL ACUITY;

EID: 34447500689     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.7.945     Document Type: Article

References (51)

1. O'Shea JG. Age-related macular degeneration. Postgrad Med J. 1998;74(870):203-207.
2. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med. 2000;342(7):483-492.
3. Gottlieb JL. Age-related macular degeneration. JAMA. 2002;288(18):2233-2236.
4. Klein R, Klein BE, Moss SE. Age-related eye disease and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 1995;113(3):333-339.
5. Coscas G. Age related macular degeneration and subretinal neovessels: primary cause of acquired blindness in adults [in French]. Rev Prat. 1991;41(23):2320-2322.
6. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102(11):1640-1642.
7. Soubrane G, Haddad WM, Coscas G. Age-related macular degeneration. Presse Med. 2002;31(27):1282-1287.
8. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl):335-610.
9. Buch H, Vinding T, la Cour M, Nielsen NV. The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2001;79(5):441-449.
10. Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology. 2005;112(5):787-798.
11. Rohrschneider K, Greim S. Epidemiology of blindness in Baden, Germany [in German]. Klin Monatsbl Augenheilkd. 2004;221(2):116-121.
12. Friedman DS, O'Colmain BJ, Munoz B, et al; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
13. Javitt JC, Zhou Z, Maguire MG, Fine SL. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology. 2003;110(8):1534-1539.
14. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
15. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 2002;109(10):1767-1779.
16. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137(3):486-495.
17. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109(6):1092-1097.
18. Mukesh BN, Dimitrov PN, Leikin S, et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology. 2004;111(6):1176-1182.
19. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology. 2000;107(8):1593-1600.
20. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP; Los Angeles Latino Eye Study Group. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(7):1288-1297.
21. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102(2):205-210.
22. Berdeaux GH, Nordmann JP, Colin E, Arnould B. Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol. 2005;139(2):271-279.
23. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108(10):1893-1900.
24. Brown GC, Brown MM, Sharma S. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration. Can J Ophthalmol. 2000;35(3):127-133.
25. Brown GC, Sharma S, Brown MM, Kistler . Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118(1):47-51 J.
26. Brown MM, Brown GC, Sharma S, Smith AF, Landy J. A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes. Int Ophthalmol. 2001;24(3):123-127.
27. Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002;120(4):481-484.
28. Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112(1):152-158.
29. Dong LM, Childs AL, Mangione CM, et al; Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report No. 4. Am J Ophthalmol. 2004;138(1):91-108.
30. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999;128(1):45-53.
31. Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. 1999;128(1):54-62.
32. Stein JD, Brown MM, Brown GC, Hollands H, Sharma S. Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br J Ophthalmol. 2003;87(1):8-12.
33. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116(4):514-520.
34. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116(11):1496-1504.
35. Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116(2):227-233.
36. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058.
37. Mitchell J, Bradle y C. Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Qual Life Res. 2004;13(6):1163-1175.
38. Mitchell J, Wolffsohn JS, Woodcock A, et al. +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health Qual Life Outcomes. 2005;3:25.
39. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics. 1995;7(6):490-502.
40. Feeny D, Furlong W, Barr RD. Multiattribute approach to the assessment of health-related quality of life: Health Utilities Index. Med Pediatr Oncol. 1998(suppl 1):54-59.
41. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index mark 3 system. Med Care. 2002;40(2):113-128.
42. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33(5):375-384.
43. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI (R)): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54.
44. Mangione CM. Version 2000: The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) scoring algorithm. http://www.nei.nih.gov/ resources/visionfunction/manual_cm2000.pdf. Accessed November 2005.
45. Furlong WJ. Health Utilities Index (HUI) Procedures Manual. Dundas, ON: Utilities Inc; 2002.
46. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N; European Regulatory Issues on Quality of Life Assessment Group. Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J. 2002;36(1):209-238.
47. Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003;110(6):1076-1081.
48. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2001;108(11):2051-2059.
49. Slakter JS, Stur M. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophthalmol. 2005;50(3):263-273.
50. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473-511.
51. Maddigan SL, Majumdar SR, Toth EL, Feeny DH, Johnson J. Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes. Health Qual Life Outcomes. 2003;1(1):78.